Targeted Medical Pharma, Inc.
TRGM · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,067 | -$3,895 | -$9,338 | -$9,586 |
| Dep. & Amort. | $231 | $402 | $412 | $436 |
| Deferred Tax | $0 | $0 | $5,666 | -$3,181 |
| Stock-Based Comp. | $95 | $656 | $745 | $1,154 |
| Change in WC | $1,113 | $3,198 | $220 | $2,161 |
| Other Non-Cash | $350 | $419 | $222 | $6,643 |
| Operating Cash Flow | -$1,279 | $780 | -$2,047 | -$2,373 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$38 | -$116 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$83 | -$179 |
| Investing Cash Flow | $0 | $0 | -$121 | -$295 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,350 | -$1,500 | $2,083 | $3,115 |
| Stock Issued | $0 | $240 | $250 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$268 |
| Financing Cash Flow | $1,350 | -$1,260 | $2,333 | $2,848 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $71 | -$480 | $165 | $179 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12 | $492 | $327 | $147 |
| End Cash | $83 | $12 | $492 | $327 |
| Free Cash Flow | -$1,279 | $780 | -$2,168 | -$2,668 |